Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 13, 292

Perplexities of Treatment Resistance in Eating Disorders


Perplexities of Treatment Resistance in Eating Disorders

Katherine A Halmi. BMC Psychiatry.


Background: Treatment resistance is an omnipresent frustration in eating disorders. Attempts to identify the features of this resistance and subsequently develop novel treatments have had modest effects. This selective review examines treatment resistant features expressed in core eating disorder psychopathology, comorbidities and biological features. Novel treatments addressing resistance are discussed.

Description: The core eating disorder psychopathology of anorexia nervosa becomes a coping mechanism likely via vulnerable neurobiological features and conditioned learning to deal with life events. Thus it is reinforcing and ego syntonic resulting in resistance to treatment. The severity of core features such as preoccupations with body image, weight, eating and exercising predicts greater resistance to treatment. Bulimia nervosa patients are less resistant to treatment with treatment failure related to greater body image concerns, impulsivity, depression, severe diet restriction and poor social adjustment. For those with binge eating disorder overweight in childhood and high emotional eating predicts treatment resistance. There is suggestive data that a diagnosis of an anxiety disorder and severe perfectionism may confer treatment resistance in anorexia nervosa and substance use disorders or personality disorders with impulse control problems may produce resistance to treatment in bulimia nervosa. Traits such as perfectionism, cognitive inflexibility and negative affect with likely genetic influences may also affect treatment resistance. Pharmacotherapy and novel therapies have been developed to address treatment resistance. Atypical antipsychotic drugs have shown some effect in treatment resistant anorexia nervosa and topiramate and high doses of SSRIs are helpful for treatment of resistant binge eating disorder patients. There are insufficient randomized controlled trials to evaluate the novel psychotherapies which are primarily based on the core psychopathological features of the eating disorders.

Conclusion: Treatment resistance in eating disorders is usually predicted by the severity of the core eating disorder psychopathology which develops from an interaction between environmental risk factors with genetic traits and a vulnerable neurobiology. Future investigations of the biological features and neurocircuitry of the core eating disorders psychopathology and behaviors may provide information for more successful treatment interventions.

Similar articles

See all similar articles

Cited by 16 articles

See all "Cited by" articles


    1. Halmi KA. Perplexities and provocations of eating disorders. J Child Psychol Psychiat. 2009;50:163–169. doi: 10.1111/j.1469-7610.2008.01983.x. - DOI - PubMed
    1. Wagner S, Halmi KA. The sense of personal ineffectiveness in patients with anorexia nervosa: one construct or several? Int J Eat Dis. 1987;6:495–505. doi: 10.1002/1098-108X(198707)6:4<495::AID-EAT2260060406>3.0.CO;2-I. - DOI
    1. Halmi KA, Agras WS, Crow S, Mitchell J, Wilson GT, Bryson SW, Kraemer C. Predictors of treatment acceptance and completion in anorexia nervosa. Arch Gen Psychiat. 2005;62:776–781. doi: 10.1001/archpsyc.62.7.776. - DOI - PubMed
    1. Agras S, Crow S, Halmi KA, Mitchell J, Wilson T, Kraemer H. Outcome predictors for the cognitive – behavioral treatment of bulimia nervosa: data from a multisite study. Am J Psychait. 2000;157:1302–1308. doi: 10.1176/appi.ajp.157.8.1302. - DOI - PubMed
    1. Ricca V, Castellini G, Mannucci E, Sauro CL, Ravaldi C, Rotella CM, Faravelli C. Comparison of individual and group cognitive behavioral therapy for binge eating disorder: a randomized, 3 year follow up study. Appetite. 2010;55:656–665. doi: 10.1016/j.appet.2010.09.019. - DOI - PubMed

MeSH terms